Gastroenterology Research and Practice
Volume 2016 (2016), Article ID 7476231, 8 pages
http://dx.doi.org/10.1155/2016/7476231
Research Article
Clinical Impact of Viral Load on the Development of Hepatocellular Carcinoma and Liver-Related Mortality in Patients with Hepatitis C Virus Infection
Division of Hepatology, Department of Internal Medicine, Dankook University College of Medicine, Dankook University Hospital, Cheonan 330-715, Republic of Korea
Received 13 March 2016; Revised 15 July 2016; Accepted 3 August 2016
Academic Editor: Kerstin Schütte
Copyright © 2016 Ran Noh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Linked References
- T. Poynard, P. Bedossa, and P. Opolon, “Natural history of liver fibrosis progression in patients with chronic hepatitis C,” The Lancet, vol. 349, no. 9055, pp. 825–832, 1997. View at Publisher · View at Google Scholar · View at Scopus
- J. F. Perz, G. L. Armstrong, L. A. Farrington, Y. J. F. Hutin, and B. P. Bell, “The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide,” Journal of Hepatology, vol. 45, no. 4, pp. 529–538, 2006. View at Publisher · View at Google Scholar · View at Scopus
- M. I. Memon and M. A. Memon, “Hepatitis C: an epidemiological review,” Journal of Viral Hepatitis, vol. 9, no. 2, pp. 84–100, 2002. View at Publisher · View at Google Scholar · View at Scopus
- G. M. Lauer and B. D. Walker, “Hepatitis C virus infection,” The New England Journal of Medicine, vol. 345, no. 1, pp. 41–52, 2001. View at Publisher · View at Google Scholar · View at Scopus
- M.-S. Lee, D.-H. Kim, H. Kim et al., “Hepatitis B vaccination and reduced risk of primary liver cancer among male adults: a cohort study in Korea,” International Journal of Epidemiology, vol. 27, no. 2, pp. 316–319, 1998. View at Publisher · View at Google Scholar · View at Scopus
- Y.-C. Chien, C.-F. Jan, H.-S. Kuo, and C.-J. Chen, “Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched,” Epidemiologic Reviews, vol. 28, no. 1, pp. 126–135, 2006. View at Publisher · View at Google Scholar · View at Scopus
- Korean National Statistical Office, Annual Report on the Causes of Death Statistics, Korean National Statistical Office, Seoul, South Korea, 2010 (Korean).
- C.-J. Chen, H.-I. Yang, J. Su et al., “Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA Level,” The Journal of the American Medical Association, vol. 295, no. 1, pp. 65–73, 2006. View at Publisher · View at Google Scholar · View at Scopus
- G. Chen, W. Lin, F. Shen, U. H. Iloeje, W. T. London, and A. A. Evans, “Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study,” American Journal of Gastroenterology, vol. 101, no. 8, pp. 1797–1803, 2006. View at Publisher · View at Google Scholar · View at Scopus
- M.-F. Yuen, Y. Tanaka, D. Y.-T. Fong et al., “Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B,” Journal of Hepatology, vol. 50, no. 1, pp. 80–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
- J.-D. Chen, H.-I. Yang, U. H. Iloeje et al., “Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death,” Gastroenterology, vol. 138, no. 5, pp. 1747–1754, 2010. View at Publisher · View at Google Scholar · View at Scopus
- J. Liu, H.-I. Yang, M.-H. Lee et al., “Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma,” Gut, vol. 63, no. 10, pp. 1648–1657, 2014. View at Publisher · View at Google Scholar · View at Scopus
- J. Bruix, M. Sherman, J. M. Llovet et al., “Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference,” Journal of Hepatology, vol. 35, no. 3, pp. 421–430, 2001. View at Publisher · View at Google Scholar · View at Scopus
- J. Bruix and M. Sherman, “Management of hepatocellular carcinoma: an update,” Hepatology, vol. 53, no. 3, pp. 1020–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
- S. Ishiguro, M. Inoue, Y. Tanaka, M. Mizokami, M. Iwasaki, and S. Tsugane, “Impact of viral load of hepatitis C on the incidence of hepatocellular carcinoma: a population-based cohort study (JPHC Study),” Cancer Letters, vol. 300, no. 2, pp. 173–179, 2011. View at Publisher · View at Google Scholar · View at Scopus
- M.-H. Lee, H.-I. Yang, S.-N. Lu et al., “Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study,” Journal of Clinical Oncology, vol. 28, no. 30, pp. 4587–4593, 2010. View at Publisher · View at Google Scholar · View at Scopus
- C. A. Sun, H. Farzadegan, S. L. You et al., “Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan,” Cancer Epidemiology, Biomarkers & Prevention, vol. 5, no. 3, pp. 173–178, 1996. View at Google Scholar
- S. C. Yates, M. Hafez, M. Beld et al., “Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with HCV RNA level,” American Journal of Tropical Medicine and Hygiene, vol. 60, no. 4, pp. 714–720, 1999. View at Google Scholar · View at Scopus
- C. Duvoux, J.-M. Pawlotsky, A. Bastie, D. Cherqui, C.-J. Soussy, and D. Dhumeaux, “Low HCV replication levels in end-stage hepatitis C virus-related liver disease,” Journal of Hepatology, vol. 31, no. 4, pp. 593–597, 1999. View at Publisher · View at Google Scholar · View at Scopus
- M. Ikeda, S. Fujiyama, M. Tanaka et al., “Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon,” Journal of Gastroenterology, vol. 40, no. 2, pp. 148–156, 2005. View at Publisher · View at Google Scholar · View at Scopus
- C.-M. Lee, C.-H. Hung, S.-N. Lu et al., “Viral etiology of hepatocellular carcinoma and HCV genotypes in Taiwan,” Intervirology, vol. 49, no. 1-2, pp. 76–81, 2006. View at Publisher · View at Google Scholar · View at Scopus
- K. Ikeda, M. Kobayashi, T. Someya et al., “Influence of hepatitis C virus subtype on hepatocellular carcinogenesis: a multivariate analysis of a retrospective cohort of 593 patients with cirrhosis,” Intervirology, vol. 45, no. 2, pp. 71–78, 2002. View at Publisher · View at Google Scholar · View at Scopus
- S. Bruno, E. Silini, A. Crosignani et al., “Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study,” Hepatology, vol. 25, no. 3, pp. 754–758, 1997. View at Publisher · View at Google Scholar · View at Scopus
- E. Silini, R. Bottelli, M. Asti et al., “Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study,” Gastroenterology, vol. 111, no. 1, pp. 199–205, 1996. View at Publisher · View at Google Scholar · View at Scopus
- E. J. Cho, S. H. Jeong, B. H. Han, S. U. Lee, B. C. Yun, and E. T. Park, “Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience,” Clinical and Molecular Hepatology, vol. 18, no. 2, pp. 219–224, 2012. View at Publisher · View at Google Scholar · View at Scopus
- A. Mangia, I. Cascavilla, G. Lezzi et al., “HCV genotypes in patients with liver disease of different stages and severity,” Journal of Hepatology, vol. 26, no. 6, pp. 1173–1178, 1997. View at Publisher · View at Google Scholar · View at Scopus
- H. Yotsuyanagi, K. Koike, K. Yasuda et al., “Hepatitis C virus genotypes and development of hepatocellular carcinoma,” Cancer, vol. 76, no. 8, pp. 1352–1355, 1995. View at Google Scholar · View at Scopus
- A. Craxì and C. Cammà, “Prevention of hepatocellular carcinoma,” Clinics in Liver Disease, vol. 9, no. 2, pp. 329–346, 2005. View at Publisher · View at Google Scholar · View at Scopus
- H. Yoshida, R. Tateishi, Y. Arakawa et al., “Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C,” Gut, vol. 53, no. 3, pp. 425–430, 2004. View at Publisher · View at Google Scholar · View at Scopus
- S. Bruno, T. Stroffolini, M. Colombo et al., “Sustained virological response to interferon-α is associated with improved outcome in HCV-related cirrhosis: a retrospective study,” Hepatology, vol. 45, no. 3, pp. 579–587, 2007. View at Publisher · View at Google Scholar · View at Scopus
- Y. Shiratori, Y. Ito, O. Yokosuka et al., “Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival,” Annals of Internal Medicine, vol. 142, no. 2, pp. 105–114, 2005. View at Google Scholar · View at Scopus
- A. S. Lok, J. E. Everhart, E. C. Wright et al., “Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C,” Gastroenterology, vol. 140, no. 3, pp. 840–849, 2011. View at Publisher · View at Google Scholar · View at Scopus
- J. Bruix, T. Poynard, M. Colombo et al., “Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C,” Gastroenterology, vol. 140, no. 7, pp. 1990–1999, 2011. View at Google Scholar
- P. Michielsen, E. Ho, and S. Francque, “Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?” Minerva Gastroenterologica e Dietologica, vol. 58, no. 1, pp. 65–79, 2012. View at Google Scholar · View at Scopus
- A. J. van der Meer, B. J. Veldt, J. J. Feld et al., “Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis,” The Journal of the American Medical Association, vol. 308, no. 24, pp. 2584–2593, 2012. View at Publisher · View at Google Scholar · View at Scopus
- A. G. Singal, M. L. Volk, D. Jensen, A. M. Di Bisceglie, and P. S. Schoenfeld, “A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus,” Clinical Gastroenterology and Hepatology, vol. 8, no. 3, pp. 280–288.e1, 2010. View at Publisher · View at Google Scholar · View at Scopus
- J. Shindoh, K. Hasegawa, Y. Matsuyama et al., “Low hepatitis c viral load predicts better long-term outcomes in patients undergoing resection of hepatocellular carcinoma irrespective of serologic eradication of hepatitis c virus,” Journal of Clinical Oncology, vol. 31, no. 6, pp. 766–773, 2013. View at Publisher · View at Google Scholar · View at Scopus
- M. E. Cramp, W. M. Rosenberg, S. D. Ryder, S. Blach, and J. Parkes, “Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality,” BMC Gastroenterology, vol. 14, article 137, 2014. View at Publisher · View at Google Scholar · View at Scopus